ELIMINATION OF FLUCONAZOLE DURING CONTINUOUS VENOVENOUS HEMODIALYSIS (CVVHD) IN A SINGLE PATIENT

被引：16

作者：

WOLTER, K

MARGGRAF, G

DERMOUMI, H

FRITSCHKA, E

机构：

[1] UNIV HOSP ESSEN,DEPT THORAC & CARDIOVASC SURG,ESSEN,GERMANY

[2] UNIV HOSP ESSEN,INST MED MICROBIOL,ESSEN,GERMANY

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1994年 / 47卷 / 03期

关键词：

FLUCONAZOLE; HEMODIALYSIS; PHARMACOKINETICS; DRUG MONITORING; CVVHD;

D O I：

10.1007/BF02570511

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：291 / 292

页数：2

共 5 条

[1] PHARMACOKINETICS OF FLUCONAZOLE IN PATIENTS UNDERGOING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J].

DEBRUYNE, D ;

RYCKELYNCK, JP ;

MOULIN, M ;

DELIGNY, BH ;

LEVALTIER, B ;

BIGOT, MC .

CLINICAL PHARMACOKINETICS, 1990, 18 (06) :491-498

[2] CLINICAL PHARMACOKINETICS OF FLUCONAZOLE [J].

DEBRUYNE, D ;

RYCKELYNCK, JP .

CLINICAL PHARMACOKINETICS, 1993, 24 (01) :10-27

[3]

OONO S, 1992, EUR J CLIN PHARMACOL, V42, P667

[4] DRUG-DOSAGE IN PATIENTS DURING CONTINUOUS RENAL REPLACEMENT THERAPY - PHARMACOKINETIC AND THERAPEUTIC CONSIDERATIONS [J].

REETZEBONORDEN, P ;

BOHLER, J ;

KELLER, E .

CLINICAL PHARMACOKINETICS, 1993, 24 (05) :362-379

[5] AN ASSESSMENT OF THE EFFECTS OF IMPAIRED RENAL-FUNCTION AND HEMODIALYSIS ON THE PHARMACOKINETICS OF FLUCONAZOLE [J].

TOON, S ;

ROSS, CE ;

GOKAL, R ;

ROWLAND, M .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 29 (02) :221-226

← 1 →